Mindfulness Meditation

Cancer Clinical Trial

Official title:

Mindfulness Meditation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05098002
• Other study ID #: I 1946021
• Status: Completed
• Phase: N/A
• Start date: January 2, 2022
• Est. completion date: November 28, 2023

Study information

• Verified date: February 2024
• Source: Roswell Park Cancer Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

To offer Roswell Park patients and caregivers a variety of options to reduce their stress and improve their psychological well-being amidst the difficulty of cancer

Recruitment information / eligibility

• Status: Completed
• Enrollment: 57
• Est. completion date: November 28, 2023
• Est. primary completion date: February 28, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Being over 18 years old

• Cancer survivor or a caregiver of cancer patient/survivor.

Exclusion Criteria:

• Unwilling or unable to complete the assessment in English.

• Are unwilling or unable to follow protocol requirements.

• Have any condition which in the Investigator's opinion deems the subject an unsuitable candidate to participate in this study including (based on criteria from the Mindfulness-based stress reduction (MBSR) authorized curriculum guide):

1. Drug addiction (or recent recovery)

2. Bereavement (recent loss)

3. Mental health inpatient (recently discharged)

4. Current depression or other major psychiatric diagnoses (including suicidality or suicidal ideation) that would interfere with participation

Related Conditions & MeSH terms

• Cancer

Intervention

Behavioral:
• Mindfulness program
6 week class designed to improve psychological well-being

Locations

Country	Name	City	State
United States	Roswell Park Comprehensive Cancer Center	Buffalo	New York

Sponsors (1)

Lead Sponsor	Collaborator
Roswell Park Cancer Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Feasibility - Enrollment rates	Number of participants enrolled in virtual classes vs in person classes	6 weeks
Secondary	Acceptability	Percentage of participants who choose in person classes vs. virtual classess	6 weeks